Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease

Acta Neuropathologica

Volumn 100, Issue 3, 2000, Pages 285-290

  Mattila, P M ^a   Rinne, J O ^a   Helenius, H ^a   Dickson, D W ^b   Roytta M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b MAYO CLINIC   (United States)

Author keywords

Alpha synuclein; Cognitive impairment; Cortical Lewy bodies; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; FEMALE; GENE DOSAGE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENILE PLAQUE; TEMPORAL CORTEX;

EID: 0033923545     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004019900168     Document Type: Article

References (37)

1. Bancher C, Braak H, Fischer P, Jellinger K (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease. Neurosci Lett 162: 179-182
2. Braak H, Braak E (1990) Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles and neuropil threads in the cerebral cortex. J Neural Transm [P-D Sect] 2: 45-57
3. Braak H, Braak E. Yilmazer D, Vos RAI de, Jansen ENH, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88: 493-500
4. Brown DF, Dahaho MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CL III (1998) Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 57: 39-46
5. Dickson DW (1998) Pick's disease: a modern approach. Brain Pathol 8: 339-354
6. Duyckaerts C, Gaspar P, Costa C, Bonnet A-M, Hauw J-J (1993) Dementia in Parkinson's disease. Morphometric data. Adv Neurol 60: 447-455
7. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55: 259-272
8. Gearing M, Schneider JA, Reheck GW, Hyman BT, Mirra SS (1995) Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 45: 1985-1990
9. Gibb WRG, Esiri MM, Lees A (1985) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110: 1131-1153
10. Gibb WRG, Luthert PJ, Janota I, Lantos PL (1989) Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 52: 185-192
11. Goldman JE, Yen S-H, Chiu F-C, Peress NS (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221: 1082-1084
12. Hansen LA, Samuel W (1997) Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 48: 126-132
13. Ince P, Irving D, MacArthur F, Perry RH (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci 106: 142-152
14. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neuntes in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57: 334-337
15. Jellinger K, Braak H, Braak E, Fischer P (1991) Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Ann NY Acad Sci 640: 203-209
16. Jendroska K, Lees AJ, Poewe W, Daniel SE (1996) Amyloid β-peptide and the dementia of Parkinson's disease. Mov Disord 11: 647-653
17. Kazee AM, Han LY (1995) Cortical Lewy bodies in Alzheimer's disease. Arch Pathol Lab Med 119: 448-453
18. Kosaka K (1978) Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol (Berl) 42: 127-134
19. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease? Clin Neuropathol 3: 185-192
20. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y (1988) Lewy bodies are ubiquitinated. A light and microscopic immunocytochemical study. Acta Neuropathol (Berl) 75: 345-353
21. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB (1989) Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 52: 1236-1247
22. Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle and Mallory bodies in alcoholic liver disease. J Pathol 155: 9-15
23. Mahler ME, Cummings JL (1990) Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alz Dis Assoc Disord 4: 133-149
24. Mattila PM, Röyttä M, Torikka H, Dickson DW, Rinne JO (1998) Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol 95: 576-582
25. Mattila PM, Koskela T, Röyttä M, Lehtimäki T, Pirttilä TA, Ilveskoski E, Karhunen P, Rinne JO (1998) Apolipoprotein E ε4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology. Acta Neuropathol 96: 417-420
26. McKeith IG, Galasko D, Kosaka K, et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124
27. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L, participating CERAD neuropathologists (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
28. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52: 183-189
29. Quinn NP, Rossor MN, Marsden CD (1986) Dementia and Parkinson's disease - pathological and neurochemical considerations. Br Med Bull 42: 86-90
30. Reisberg B (1985) Alzheimer's disease update. Psychiatr Ann 15: 319-322
31. Rinne JO, Rummukainen J, Paljärvi L, Rinne UK (1989) Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26: 47-50
32. SAS/STAT User's Guide (1990) Version 6, 4th edn. SAS Institute, Cary
33. Samuel W, Galasko D, Masliah E. Hansen LA (1996) Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 55: 44-52
34. Samuel W, Alford M, Hofstetter CR, Hansen L (1997) Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction and synapse density. J Neuropathol Exp Neurol 56: 499-508
35. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388: 839-840
36. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95: 6469-6473
37. Yoshimura M (1983) Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease". J Neurol 229:17-32